Research Article
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
Table 1
Summary of groups information.
| Groups | Drug | Concentration | Administration | Volume | |
| Group 1 | Tigecycline | 1 mg/mL | Topical | 50 L | 8 | Group 2 | Saline | 0.9% | Topical | 50 L | 8 | Group 3 | Tigecycline | 1 mg/mL | Subconjunctival | 0.05 mL | 8 | Group 4 | Saline | 0.9% | Subconjunctival | 0.05 mL | 8 |
|
|